Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1997;5(5):349–354. doi: 10.1155/S1064744997000616

Detection of Antibodies to Chlamydia trachomatis With Peptide-Based Species-Specific Enzyme Immunoassay

Ale Närvänen 1,5,✉, Mirja Puolakkainen 2, Wu Hao 1, Kohsuke Kino 3, Jukka Suni 4
PMCID: PMC2364578  PMID: 18476184

Abstract

Objective: We have evaluated the sensitivity and specificity of a new synthetic peptide-based species-specific enzyme immunoassay (EIA) for detection of Chlamydia trachomatis IgG and IgA antibodies.

Methods: Synthetic peptides derived from variable domain IV of major outer membrane protein (MOMP) were used as antigen in indirect EIA. IgG and IgA antibodies were measured in parallel with serum samples from C. trachomatis culture positive, culture negative, and antigen positive patients, and women with suspected C. trachomatis infection and blood donors. Sera from children under 15 years of age were used as controls.

Results: Culture positive women, culture positive men, and antigen positive women had positive peptide serology in 84.2%, 61.3%, and 93.1% of the cases, respectively. Among C. trachomatis suspected women, the antibody prevalence was 63.6%. Randomly collected blood donors showed a prevalence of 21.5%. Children with C. pneumoniae antibodies determined with the microimmuno-fluorescence (MIF) method did not show any reactivity in the C. trachomatis peptide EIA.

Conclusions: The results suggest that the new EIA test is highly specific for C. trachomatis, and C. pneumoniae antibodies do not interfere. Both IgG and IgA antibodies appear within at least 2 weeks in acute phase of infection among both culture positive and culture negative patients.

Full Text

The Full Text of this article is available as a PDF (482.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjercke S., Purvis K. Characteristics of women under fertility investigation with IgA/IgG seropositivity for Chlamydia trachomatis. Eur J Obstet Gynecol Reprod Biol. 1993 Oct;51(2):157–161. doi: 10.1016/0028-2243(93)90028-b. [DOI] [PubMed] [Google Scholar]
  2. Cevenini R., Sarov I., Rumpianesi F., Donati M., Melega C., Varotti C., La Placa M. Serum specific IgA antibody to Chlamydia trachomatis in patients with chlamydial infections detected by ELISA and an immunofluorescence test. J Clin Pathol. 1984 Jun;37(6):686–691. doi: 10.1136/jcp.37.6.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clad A., Flecken U., Petersen E. E. Chlamydial serology in genital infections: ImmunoComb versus Ipazyme. Infection. 1993 Nov-Dec;21(6):384–389. doi: 10.1007/BF01728919. [DOI] [PubMed] [Google Scholar]
  4. Dabekausen Y. A., Evers J. L., Land J. A., Stals F. S. Chlamydia trachomatis antibody testing is more accurate than hysterosalpingography in predicting tubal factor infertility. Fertil Steril. 1994 May;61(5):833–837. doi: 10.1016/s0015-0282(16)56692-8. [DOI] [PubMed] [Google Scholar]
  5. Eggert-Kruse W., Gerhard I., Näher H., Tilgen W., Runnebaum B. Chlamydial infection--a female and/or male infertility factor? Fertil Steril. 1990 Jun;53(6):1037–1043. doi: 10.1016/s0015-0282(16)53581-x. [DOI] [PubMed] [Google Scholar]
  6. Jaczek K. H. Genital Chlamydia trachomatis: detection, treatment and patient education. Can Fam Physician. 1985 Oct;31:1861–1865. [PMC free article] [PubMed] [Google Scholar]
  7. Jones H. M., Schachter J., Stephens R. S. Evaluation of the humoral immune response in trachoma to Chlamydia trachomatis major outer membrane proteins by sequence-defined immunoassay. J Infect Dis. 1992 Oct;166(4):915–919. doi: 10.1093/infdis/166.4.915. [DOI] [PubMed] [Google Scholar]
  8. Kumamoto Y., Sato T., Hiroi M., Hashizume S., Nakata H., Kojima H., Matsuda S., Yamazaki S., Sugao M., Noguchi M. Assessment of Chlamydia trachomatis-specific IgA and IgG serum antibodies in genitourinary Chlamydia trachomatis infection--comparative study between HITAZYME and IPAzyme. Kansenshogaku Zasshi. 1993 Apr;67(4):315–330. doi: 10.11150/kansenshogakuzasshi1970.67.315. [DOI] [PubMed] [Google Scholar]
  9. Nagy B., Corradi G., Vajda Z., Gimes R., Csömör S. The occurrence of Chlamydia trachomatis in the semen of men participating in an IVF programme. Hum Reprod. 1989 Jan;4(1):54–56. doi: 10.1093/oxfordjournals.humrep.a136845. [DOI] [PubMed] [Google Scholar]
  10. Norrby E., Biberfeld G., Chiodi F., von Gegerfeldt A., Nauclér A., Parks E., Lerner R. Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature. 1987 Sep 17;329(6136):248–250. doi: 10.1038/329248a0. [DOI] [PubMed] [Google Scholar]
  11. Närvänen A., Korkolainen M., Suni J., Korpela J., Kontio S., Partanen P., Vaheri A., Huhtala M. L. Synthetic env gp41 peptide as a sensitive and specific diagnostic reagent in different stages of human immunodeficiency virus type 1 infection. J Med Virol. 1988 Oct;26(2):111–118. doi: 10.1002/jmv.1890260202. [DOI] [PubMed] [Google Scholar]
  12. Paavonen J., Wølner-Hanssen P. Chlamydia trachomatis: a major threat to reproduction. Hum Reprod. 1989 Feb;4(2):111–124. doi: 10.1093/oxfordjournals.humrep.a136855. [DOI] [PubMed] [Google Scholar]
  13. Piura B., Sarov I., Sarov B., Kleinman D., Chaim W., Insler V. Serum IgG and IgA antibodies specific for Chlamydia trachomatis in salpingitis patients as determined by the immunoperoxidase assay. Eur J Epidemiol. 1985 Jun;1(2):110–116. doi: 10.1007/BF00141802. [DOI] [PubMed] [Google Scholar]
  14. Quinn T. C., Welsh L., Lentz A., Crotchfelt K., Zenilman J., Newhall J., Gaydos C. Diagnosis by AMPLICOR PCR of Chlamydia trachomatis infection in urine samples from women and men attending sexually transmitted disease clinics. J Clin Microbiol. 1996 Jun;34(6):1401–1406. doi: 10.1128/jcm.34.6.1401-1406.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stamm W. E., Koutsky L. A., Benedetti J. K., Jourden J. L., Brunham R. C., Holmes K. K. Chlamydia trachomatis urethral infections in men. Prevalence, risk factors, and clinical manifestations. Ann Intern Med. 1984 Jan;100(1):47–51. doi: 10.7326/0003-4819-100-1-47. [DOI] [PubMed] [Google Scholar]
  16. Stephens R. S., Tam M. R., Kuo C. C., Nowinski R. C. Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. J Immunol. 1982 Mar;128(3):1083–1089. [PubMed] [Google Scholar]
  17. Thejls H., Rahm V. A., Rosen G., Gnarpe H. Correlation between chlamydia infection and clinical evaluation, vaginal wet smear, and cervical swab test in female adolescents. Am J Obstet Gynecol. 1987 Oct;157(4 Pt 1):974–976. doi: 10.1016/s0002-9378(87)80098-4. [DOI] [PubMed] [Google Scholar]
  18. Toye B., Peeling R. W., Jessamine P., Claman P., Gemmill I. Diagnosis of Chlamydia trachomatis infections in asymptomatic men and women by PCR assay. J Clin Microbiol. 1996 Jun;34(6):1396–1400. doi: 10.1128/jcm.34.6.1396-1400.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Van der Pol B., Williams J. A., Jones R. B. Rapid antigen detection assay for identification of Chlamydia trachomatis infection. J Clin Microbiol. 1995 Jul;33(7):1920–1921. doi: 10.1128/jcm.33.7.1920-1921.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ward M. E. The immunobiology and immunopathology of chlamydial infections. APMIS. 1995 Nov;103(11):769–796. doi: 10.1111/j.1699-0463.1995.tb01436.x. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES